Welcome to our dedicated page for Brookline Bncp SEC filings (Ticker: BRKL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Digging through Brookline Bancorp’s 200-page 10-K to untangle loan-loss reserves, capital ratios, and segment yield data can feel overwhelming. Regulatory language specific to community banks, combined with multiple subsidiary disclosures, makes Brookline’s filings uniquely dense—even seasoned analysts struggle to pinpoint which credit trends or deposit shifts really matter.
Stock Titan’s AI bridges that gap. Our platform ingests every Brookline Bancorp quarterly earnings report 10-Q filing, proxy statement on executive compensation, and 8-K material event the moment it hits EDGAR. Then we generate plain-English summaries that highlight net interest margin changes, CECL adjustments, and regional loan concentrations—so you can understand Brookline Bancorp SEC documents with AI in minutes, not hours. Need to follow Brookline Bancorp insider trading Form 4 transactions? Real-time alerts surface executive stock transactions, giving you context before the market reacts.
Whether you’re screening credit quality ahead of the next rate cycle, tracking Brookline Bancorp annual report 10-K simplified insights for dividend sustainability, or comparing branch-level deposit growth, every filing type is covered. Use our AI commentary to:
- Monitor Brookline Bancorp Form 4 insider transactions real-time
- Quickly compare past quarters with our earnings report filing analysis
- Decode Brookline Bancorp proxy statement executive compensation without spreadsheets
- Flag key 8-K material events explained for sudden credit actions
Safe & Green Holdings Corp. (Nasdaq: SGBX) has called a virtual special meeting for 25 Aug 2025 to seek shareholder approval on three key items:
- Proposal 1 – Reverse Stock Split: Board discretion to combine shares at any ratio between 1-for-10 and 1-for-100 within one year. Main objective is to lift the bid price above Nasdaq’s US$1.00 minimum after two deficiency notices and a Hearing Panel deadline of 28 Aug 2025.
- Proposal 2 – Issuance of Series B Preferred Conversion Shares: Approval under Nasdaq Rule 5635(d) to issue all common shares underlying 60,000 newly issued Series B convertible preferred shares obtained via a warrant-for-preferred exchange completed 17 Jul 2025. Conversion price is US$0.392 per share but is capped at 19.99 % of outstanding common stock until shareholder consent is obtained.
- Proposal 3 – Adjournment: Authority to adjourn the meeting to solicit additional proxies if needed.
The record date is 11 Jul 2025 with 10,120,651 common shares outstanding. A quorum requires one-third of voting power. The board recommends voting FOR all proposals. Failure to effect the reverse split and regain compliance could lead to delisting; conversely, approval would give management flexibility to meet Nasdaq conditions but may increase dilution and market volatility for existing investors.